ArticleScientific reports2026
Prostate cancer detection using modified transformer with optimal feature selection from MRI images.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer is one of the most prevalent malignancies among men, and early detection through Magnetic Resonance Imaging (MRI) plays a crucial role in improving patient outcomes. However, accurate identification of cancerous regions remains challenging due to image noise, variations in tissue structures, and subtle differences between benign and malignant lesions. To address these challenges, a novel automated detection framework named Prostate Cancer Detection Neural Network (ProstateNet) that enhances the precision of prostate cancer detection is proposed. The proposed model begins with MRI image preprocessing using a Bilateral Filter, which effectively reduces noise while preserving edge details. Next, feature extraction is performed using a Residual Recurrent Model (RRM), which captures spatial dependencies and fine-grained image representations. To refine the extracted features, we employ the Iterative Secrecy Bird Optimization (ISBO) algorithm, ensuring optimal feature selection and reducing computational complexity. Finally, disease detection is carried out using a Modified Transformer model, which considers CapsuleNet instead of Feed Forward Network to accurately classify cancerous and non-cancerous regions. The integration of these advanced techniques significantly enhances the robustness and reliability of prostate cancer detection, offering a promising outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.